Table 3: Comparisons on the aspect of glucose metabolism.

Group Time HbA1c (%) FPG (mmol/L) 2hPG (mmol/L) FINS (μIU/mL) HOMA-IR
Before 7.35 ± 0.89 7.69 ± 1.03 12.02 ± 1.77 19.10 ± 7.36 6.53 ± 2.61
Control After 6.95 ± 0.75 7.05 ± 0.98 10.95 ± 2.34 17.81 ± 7.89 5.57 ± 2.55
*P 0.039 0.007 0.027 0.465 0.109
Before 7.28 ± 1.02 7.76 ± 0.97 11.81 ± 2.07 19.24 ± 8.82 6.64 ± 3.19
Treated After 6.44 ± 0.83 6.50 ± 1.06 9.91 ± 1.99 16.40 ± 8.53 4.75 ± 2.64
*P < 0.001 < 0.001 < 0.001 0.153 0.006
#P 0.008 0.025 0.043 0.464 0.178

*P value refers to comparison between before vs. after treatment within each group; #P value refers to comparison between treated and control groups after treatment; HbA1c: Glycosylated Hemoglobin; FPG: Fasting Plasma Glucose; 2hPG: 2h Post-Prandial Plasma Glucose; FINS: Fasting Insulin; HOMA-IR: Homeostatic Model Assessment for Insulin Resistance.